The Brand Name JANUVIA Has Generic Salt :: SITAGLIPTIN 

JANUVIA  Is From Company MSD PH. Priced :: Rs. 299

JANUVIA have SITAGLIPTIN is comes under Sub class Insulin , Anti Diabetic drugs of  Main Class Endocrine,Steroid Hormones , Metabolic System

Main Medicine Class:: Endocrine,Steroid Hormones , Metabolic System  Sub Medicine Class :: Insulin , Anti Diabetic drugs 

 Salt Name :  OR Generic Name Form Price : MRP /Probable Packing
SITAGLIPTIN    Rs. 299  –
Brand Name Company / Manufacturers Strength Unit Price / –
 JANUVIA  MSD PH.  100MG  – Rs. 299

Company  Brand Name  Salt Combination Main Medical Class Sub Medical Class
 From MSD PH. :: JANUVIA  SITAGLIPTIN  Endocrine,Steroid Hormones , Metabolic System Insulin , Anti Diabetic drugs

Indications for Drugs ::

Type 2 diabetes mellitus

Drug Dose ::

The recommended dose of Sitagliptin is 100 mg once daily. Sitagliptin can be taken with or without food. For patients with mild renal insufficiency ( creatinine clearance [CrCl]>50ml/min), no dosage adjustment is required. Renal impairment: CrCl (ml/min) 30-<50 50 mg daily. <30 25 mg daily; may be given without regard to the timing of the haemodialysis. Pediatric Use: Safety and effectiveness of Sitagliptin in pediatric patients under 18 years of age have not been established. Contraindication ::

Hypersensitivity reactions such as anaphylaxis, angioedema, and exfoliative skin conditions including Stevens-Johnson syndrome can occur. Type 1 diabetes. Diabetic ketoacidosis.

Drug Precautions ::

Discontinue treatment if there are signs of hypersensitivity. Caution when used with sulphonylureas and/or other antidiabetic medications; monitor blood glucose regularly. Renal impairment; dose adjustment may be needed. Children <18 yr. Pregnancy, lactation. Drug Side Effects ::

Headache, diarrhoea, upper respiratory tract infection, nasopharyngitis. Angioedema, exfoliative dermatitis. Hypoglycemia occurs in patients treated with the combination of Sitagliptin and sulfonylurea, with or without Metformin. Potentially Fatal: Anaphylaxis and/or severe dermatologic reactions such as Stevens-Johnson syndrome.

Pregnancy category ::
Pregnancy category

2

Drug Mode of Action ::  

Sitagliptin inhibits dipeptidyl peptidase IV (DPP-IV), resulting in prolonged active incretin levels. Incretin hormones increases insulin synthesis and release from pancreatic ?-cells and reduces glucagon secretion from pancreatic ?-cells. Reduced glucagon secretion leads to decreased hepatic glucose production.

Drug Interactions ::

Increased risk of hypoglycaemia when used in combination w/ sulfonylureas or insulin.

 

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.

DOWNLOAD OUR ANDROID APP

One of the 1st in India.High Quality Generic Medicine Portal Android Application for Online Oreder & Information.

For More Join Our Membership and Get Additional 25% off on Meds, also get MLM Benefits to get a permanent earning source.

Join Membership How to Search Medicine
Android App

We would like to keep you updated with special notifications.